SB-773812

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SB-773812, covering 2017-03-23 to 2017-08-17. Get the full timeline:

Most recent: Clinical Trial Update: SPECT Study With SB-773812 In Schizophrenic Patients [Phase 1]